IMDX
Creative Planning’s Insight Molecular Diagnostics Inc. Common Stock IMDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-12,136
| Closed | -$2.79K | – | 2881 |
|
|
2023
Q2 | $2.79K | Buy |
+12,136
| New | +$2.79K | ﹤0.01% | 2524 |
|
|
2023
Q1 | – | Sell |
-18,609
| Closed | -$5.97K | – | 2611 |
|
|
2022
Q4 | $5.97K | Hold |
18,609
| – | – | ﹤0.01% | 2342 |
|
|
2022
Q3 | $14K | Hold |
18,609
| – | – | ﹤0.01% | 2162 |
|
|
2022
Q2 | $17K | Buy |
18,609
+3,300
| +22% | +$3.02K | ﹤0.01% | 2120 |
|
|
2022
Q1 | $23K | Hold |
15,309
| – | – | ﹤0.01% | 2105 |
|
|
2021
Q4 | $33K | Buy |
+15,309
| New | +$33K | ﹤0.01% | 2021 |
|
|
2017
Q3 | – | Sell |
-250
| Closed | -$1K | – | 3035 |
|
|
2017
Q2 | $1K | Hold |
250
| – | – | ﹤0.01% | 4357 |
|
|
2017
Q1 | $1K | Sell |
250
-15
| -6% | -$60 | ﹤0.01% | 4357 |
|
|
2016
Q4 | $2K | Hold |
265
| – | – | ﹤0.01% | 4170 |
|
|
2016
Q3 | $1K | Hold |
265
| – | – | ﹤0.01% | 4252 |
|
|
2016
Q2 | $1K | Sell |
265
-50
| -16% | -$189 | ﹤0.01% | 4062 |
|
|
2016
Q1 | $1K | Buy |
+315
| New | +$1K | ﹤0.01% | 4044 |
|